CDC advisory committee unanimously recommends Pfizer’s pediatric COVID-19 vaccine

The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices today recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11. The 14-0 vote paves the way for the first doses to be administered to that age group, pending approval by CDC Director Rochelle Walensky, M.D. Across its deliberations, the committee urged thorough, clear communications with families of potential-but-rare side effects, including myocarditis, with information on symptoms and where to seek medical care.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…